Luye Pharma Group Ltd. (HKG:2186)
Hong Kong · Delayed Price · Currency is HKD 1.920
+0.010 (0.52%)
Jul 10, 2026, 4:08 PM HKT
Luye Pharma Group Market Cap
Luye Pharma Group has a market cap or net worth of 7.67 billion as of July 10, 2026. Its market cap has decreased by -40.90% in one year.
Market Cap
7.67B
Enterprise Value
13.35B
Revenue
7.02B
Ranking
n/a
PE Ratio
10.86
Stock Price
1.92
Market Cap Chart
Since July 9, 2014, Luye Pharma Group's market cap has increased from 2.95B to 7.67B, an increase of 159.67%. That is a compound annual growth rate of 8.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 7.67B | -29.93% |
| Dec 31, 2025 | 10.94B | 34.08% |
| Dec 31, 2024 | 8.16B | -41.82% |
| Dec 29, 2023 | 14.03B | 8.00% |
| Dec 30, 2022 | 12.99B | 3.05% |
| Dec 31, 2021 | 12.61B | 7.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Consun Pharmaceutical Group | 11.41B |
| CanSino Biologics | 9.89B |
| Shandong Xinhua Pharmaceutical Company | 9.46B |
| Sihuan Pharmaceutical Holdings Group | 7.67B |
| China Traditional Chinese Medicine Holdings Co. | 7.20B |
| CF PharmTech | 7.19B |
| Shanghai Fudan-Zhangjiang Bio-Pharmaceutical | 7.17B |
| SSY Group | 6.74B |